Allstate Corporation’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Sell
10,861
-471
-4% -$57.9K 0.01% 600
2026
Q1
$1.34M Buy
+11,332
New +$1.58M 0.01% 697

Other funds holding RGEN

Allstate Corporation's RGEN Position: Q2 2026 in Review

Allstate Corporation reduced its Repligen (RGEN) stake by 4.2% in Q2 2026, selling an estimated $57.9K and leaving 10,861 shares worth $1.48M. The position accounts for 0.01% of the portfolio, ranked #600.

Allstate Corporation first reported a position in RGEN in Q1 2026 and has held it in 2 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Allstate Corporation held 10,861 shares of Repligen worth $1.48M as of Q2 2026.
  • Allstate Corporation sold 471 Repligen shares in Q2 2026, an estimated $57.9K.
  • Repligen made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #600 holding.
  • Allstate Corporation first reported a position in Repligen in Q1 2026 and has held it in 2 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.